Metformin and Phenformin (cas 114-86-3) block the peripheral antinociception induced by diclofenac and indomethacin on the formalin test
-
Add time:08/27/2019 Source:sciencedirect.com
AimsRecent evidence has shown that systemic administration of sulfonylureas and biguanides block the diclofenac-induced antinociception, but not the effect produced by indomethacin. However, there are no reports about the peripheral interaction between analgesics and the biguanides metformin and Phenformin (cas 114-86-3). Therefore, this work was undertaken to determine whether glibenclamide and glipizide and the biguanides metformin and phenformin have any effect on the peripheral antinociception induced by diclofenac and indomethacin.
We also recommend Trading Suppliers and Manufacturers of Phenformin (cas 114-86-3). Pls Click Website Link as below: cas 114-86-3 suppliers
Prev:Graphene and CdS nanocomposite: A facile interface for construction of DNA-based electrochemical biosensor and its application to the determination of Phenformin (cas 114-86-3)
Next:Molecular and Cellular PharmacologyPhenformin (cas 114-86-3) has a direct inhibitory effect on the ATP-sensitive potassium channel) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- ArticleLKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin (cas 114-86-3)08/29/2019
- Molecular and Cellular PharmacologyPhenformin (cas 114-86-3) has a direct inhibitory effect on the ATP-sensitive potassium channel08/28/2019
- Graphene and CdS nanocomposite: A facile interface for construction of DNA-based electrochemical biosensor and its application to the determination of Phenformin (cas 114-86-3)08/26/2019
- Phenformin (cas 114-86-3)-loaded polymeric micelles for targeting both cancer cells and cancer stem cells in vitro and in vivo08/25/2019
- Original ArticleMelanocytes/MelanomaPhenformin (cas 114-86-3) Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma08/24/2019
- Original ArticleMelanocytes/MelanomaPhenformin (cas 114-86-3) Enhances the Efficacy of ERK Inhibition in NF1-Mutant Melanoma08/23/2019
- ReportPhenformin (cas 114-86-3), But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation08/22/2019